Press Release / Feb 18, 2022
Hovione increases prices for its off-patent Active Pharmaceutical Ingredients, Portfolio Products as well as Development and Manufacturing Services
News release, 18 February 2022
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
News release, 18 February 2022
C&EN, 17 January 2022
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
World’s largest selling disposable DPI.
Disposable DPI for high dose drug delivery.
Easy-to-use, multi-use capsule DPI.
Ultra-affordable, multi-use blister DPI.